Cargando…
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells
The ability of noncytolytic Lyt-1+,2- T cells immune to FBL-3 leukemia to effect eradication of disseminated FBL-3 was studied. Adult thymectomized, irradiated, and T-depleted bone marrow-reconstituted (ATXBM) B6 hosts were cured of disseminated FBL-3 by treatment with 180 mg/kg cyclophosphamide (CY...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187611/ https://www.ncbi.nlm.nih.gov/pubmed/3921652 |
Ejemplares similares
-
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes
Publicado: (1981) -
Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo
Publicado: (1981) -
Expression of Lyt-1 antigen on certain murine B cell lymphomas
Publicado: (1981) -
Armed and accurate: engineering cytotoxic T cells for eradication of leukemia
por: Radic, Marko
Publicado: (2012) -
Cyclophosphamide eradicates murine immunogenic tumor coding for a
non-self-antigen and induces antitumor immunity
por: Salem, Mohamed L, et al.
Publicado: (2018)